https://www.selleckchem.com/products/fiin-2.html
Clozapine is an atypical antipsychotic drug eligible for treatment-resistant schizophrenia. It frequently represents the best and the only choice in resistant schizophrenia. However, its use is feared by many professionals due to its possible adverse effects, such as eosinophilia. We report a case of a young white male suffering from treatment-resistant schizophrenia who rapidly developed eosinophilia after starting clozapine. We present a case of a 26-year-old white man diagnosed with schizophrenia with poor clinical response to several
Like
Comment
Share
